keyword
https://read.qxmd.com/read/38653916/perforated-appendicitis-in-children-management-microbiology-and-antibiotic-stewardship
#21
REVIEW
Katherine B Snyder, Catherine J Hunter, Christie L Buonpane
Although appendicitis has been described for more than 300 years, its optimal management remains a topic of active investigation. Acute appendicitis is the most common cause of peritonitis in children, and rates of perforated appendicitis are much higher in children than in adults. Increased risk for perforated appendicitis in children is related to a delay in diagnosis due to age, size, access to care, and more. Surgical options include immediate appendectomy versus nonoperative management with intravenous antibiotics ± a drainage procedure, with a subsequent interval appendectomy...
April 24, 2024: Paediatric Drugs
https://read.qxmd.com/read/38653721/prognosis-and-clinical-management-of-asymptomatic-family-members-with-ryr2-mediated-catecholaminergic-polymorphic-ventricular-tachycardia-a-review
#22
REVIEW
Puck J Peltenburg, Harry Gibson, Arthur A M Wilde, Christian van der Werf, Sally-Ann B Clur, Nico A Blom
Despite its low prevalence, the potential diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT) should be at the forefront of a paediatric cardiologists mind in children with syncope during exercise or emotions. Over the years, the number of children with a genetic diagnosis of CPVT due to a (likely) pathogenic RYR2 variant early in life and prior to the onset of symptoms has increased due to cascade screening programmes. Limited guidance for this group of patients is currently available...
April 24, 2024: Cardiology in the Young
https://read.qxmd.com/read/38649595/crocus-a-phase-ii-study-evaluating-the-antiviral-activity-clinical-outcomes-and-safety-of-rilematovir-in-children-aged-%C3%A2-%C3%A2-28-days-and-%C3%A2-%C3%A2-3-years-with-acute-respiratory-tract-infection-due-to-respiratory-syncytial-virus
#23
JOURNAL ARTICLE
Fernando Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Cristina Calvo, Silvina Natalini, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens
BACKGROUND: Respiratory syncytial virus (RSV) causes significant morbidity and mortality in children aged ≤ 5 years and adults aged ≥ 60 years worldwide. Despite this, RSV-specific therapeutic options are limited. Rilematovir is an investigational, orally administered inhibitor of RSV fusion protein-mediated viral entry. OBJECTIVE: To establish the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir (low or high dose) in children aged ≥ 28 days and ≤ 3 years with RSV disease...
April 22, 2024: Paediatric Drugs
https://read.qxmd.com/read/38648808/tackling-the-threat-of-antimicrobial-resistance-in-neonates-and-children-outcomes-from-the-first-who-convened-paediatric-drug-optimisation-exercise-for-antibiotics
#24
REVIEW
Alasdair Bamford, Tiziana Masini, Phoebe Williams, Mike Sharland, Valeria Gigante, Devika Dixit, Hatim Sati, Benedikt Huttner, Yasir Bin Nisar, Bernadette Cappello, Wilson Were, Jennifer Cohn, Martina Penazzato
Children and neonates are highly vulnerable to the impact of antimicrobial resistance. Substantial barriers are faced in relation to research and development of antibacterial agents for use in neonates, children, and adolescents aged yonger than 19 years, and focusing finite resources on the most appropriate agents for development and paediatric optimisation is urgently needed. In November and December, 2022, following the successes of previous similar disease-focused exercises, WHO convened the first Paediatric Drug Optimisation (PADO) exercise for antibiotics, aiming to provide a shortlist of antibiotics to be prioritised for paediatric research and development, especially for use in regions with the highest burden of disease attributable to serious bacterial infection...
April 19, 2024: Lancet Child & Adolescent Health
https://read.qxmd.com/read/38644704/vigilance-needed-in-treating-a-child-with-disseminated-tb-a-case-report
#25
Hemasri Velmurugan, Krishnapriya Neelambaran, Meenalotchini Prakash Gurunthalingam, Dushyant Chouhan, Pugazhenthan Thangaraju, Bikram Keshari Kar, Nitin Rewaram Gaikwad
BACKGROUND: Tuberculosis is still one of the biggest causes of infection-related death around the world. Disseminated tuberculosis is a potentially fatal disease caused by the haematogenous spread of Mycobacterium tuberculosis. First-line anti-tuberculosis drugs in-clude isoniazid, rifampicin, pyrazinamide, and ethambutol. The first three drugs are known to cause hepatotoxicity. CASE PRESENTATION: We have, herein, reported a case of Drug-induced Liver Injury (DILI) due to anti-tuberculosis therapy in a one-year-old male child with disseminated tuberculosis...
April 19, 2024: Infectious Disorders Drug Targets
https://read.qxmd.com/read/38644588/randomised-clinical-trial-first-line-infliximab-biosimilar-is-cost-effective-compared-to-conventional-treatment-in-paediatric-crohn-s-disease
#26
JOURNAL ARTICLE
Stephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, Maarten A Cozijnsen, Merel van Pieterson, Tim G J de Meij, Obbe F Norbruis, Michael Groeneweg, Victorien M Wolters, Herbert van Wering, Thalia Hummel, Janneke Stapelbroek, Cathelijne van der Feen, Patrick F van Rheenen, Michiel P van Wijk, Sarah Teklenburg, Dimitris Rizopoulos, Marten J Poley, Johanna C Escher, Lissy de Ridder
BACKGROUND: Data on cost-effectiveness of first-line infliximab in paediatric patients with Crohn's disease are limited. Since biologics are increasingly prescribed and accompanied by high costs, this knowledge gap needs to be addressed. AIM: To investigate the cost-effectiveness of first-line infliximab compared to conventional treatment in children with moderate-to-severe Crohn's disease. METHODS: We included patients from the Top-down Infliximab Study in Kids with Crohn's disease randomised controlled trial...
April 21, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38643809/paediatric-clinical-study-of-3d-printed-personalised-medicines-for-rare-metabolic-disorders
#27
JOURNAL ARTICLE
Lucía Rodríguez-Pombo, María José de Castro-López, Paula Sánchez-Pintos, Jose Maria Giraldez-Montero, Patricija Januskaite, Goretti Duran-Piñeiro, M Dolores Bóveda, Carmen Alvarez-Lorenzo, Abdul W Basit, Alvaro Goyanes, Maria L Couce
Rare diseases are infrequent, but together they affect up to 6-10 % of the world's population, mainly children. Patients require precise doses and strict adherence to avoid metabolic or cardiac failure in some cases, which cannot be addressed in a reliable way using pharmaceutical compounding. 3D printing (3DP) is a disruptive technology that allows the real-time personalization of the dose and the modulation of the dosage form to adapt the medicine to the therapeutic needs of each patient. 3D printed chewable medicines containing amino acids (citrulline, isoleucine, valine, and isoleucine and valine combinations) were prepared in a hospital setting, and the efficacy and acceptability were evaluated in comparison to conventional compounded medicines in six children...
April 19, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38643018/long-term-neuropsychological-trajectories-in-children-with-epilepsy-does-surgery-halt-decline
#28
JOURNAL ARTICLE
Maria H Eriksson, Freya Prentice, Rory J Piper, Konrad Wagstyl, Sophie Adler, Aswin Chari, John Booth, Friederike Moeller, Krishna Das, Christin Eltze, Gerald Cooray, Ana Perez Caballero, Lara Menzies, Amy McTague, Sara Shavel-Jessop, Martin M Tisdall, J Helen Cross, Patricia Martin Sanfilippo, Torsten Baldeweg
Neuropsychological impairments are common in children with drug-resistant epilepsy. It has been proposed that epilepsy surgery may alleviate these impairments by providing seizure freedom; however, findings from prior studies have been inconsistent. We mapped long-term neuropsychological trajectories in children before and after undergoing epilepsy surgery, to measure the impact of disease course and surgery on functioning. We performed a retrospective cohort study of 882 children who had undergone epilepsy surgery at Great Ormond Street Hospital (1990-2018)...
April 20, 2024: Brain
https://read.qxmd.com/read/38637310/posaconazole-in-paediatric-malignancy-and-haematopoietic-stem-cell-transplant-dosing-to-achieve-therapeutic-concentration
#29
JOURNAL ARTICLE
Heather Weerdenburg, Hannah Walker, Nigel Curtis, Stephen Duffull, Gabrielle Haeusler, Theresa Cole, Amanda Gwee
OBJECTIVES: Posaconazole is increasingly used for the treatment and prophylaxis of invasive fungal infections in immunocompromised children. We aimed to review evidence for paediatric posaconazole dosing regimens focusing on attainment of target concentrations and frequency of adverse effects. METHODS: In May 2023, the Cochrane, Embase, MEDLINE and PubMed databases were searched for articles reporting posaconazole dosing in children with malignancy or post-haematopoietic stem cell transplantation...
April 18, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38636725/d3-penta-21-clinical-trial-design-a-randomised-non-inferiority-trial-with-nested-drug-licensing-substudy-to-assess-dolutegravir-and-lamivudine-fixed-dose-formulations-for-the-maintenance-of-virological-suppression-in-children-with-hiv-1-infection-aged-2-to
#30
JOURNAL ARTICLE
Anna Turkova, Man K Chan, Cissy Kityo, Adeodata R Kekitiinwa, Philippa Musoke, Avy Violari, Ebrahim Variava, Moherndran Archary, Tim R Cressey, Suwalai Chalermpantmetagul, Kanokkorn Sawasdichai, Pradthana Ounchanum, Suparat Kanjanavanit, Sakulrat Srirojana, Ussanee Srirompotong, Steven Welch, Alasdair Bamford, Cristina Epalza, Clàudia Fortuny, Angela Colbers, Eleni Nastouli, Simon Walker, Dan Carr, Magda Conway, Moira J Spyer, Nazia Parkar, Iona White, Alessandra Nardone, Margaret J Thomason, Rashida A Ferrand, Carlo Giaquinto, Deborah Ford
BACKGROUND: There is increasing interest in utilising two-drug regimens for HIV treatment with the goal of reducing toxicity and improve acceptability. The D3 trial evaluates the efficacy and safety of DTG/3TC in children and adolescents and includes a nested pharmacokinetics(PK) substudy for paediatric drug licensing. METHODS: D3 is an ongoing open-label, phase III, 96-week non-inferiority randomised controlled trial(RCT) conducted in South Africa, Spain, Thailand, Uganda and the United Kingdom...
April 16, 2024: Contemporary Clinical Trials
https://read.qxmd.com/read/38636110/a-systematic-review-of-the-mozart-effect-in-adult-and-paediatric-cases-of-drug-resistant-epilepsy-a-sound-approach-to-epilepsy-management
#31
REVIEW
Lucrezia Maria Piccicacchi, Domenico Serino
OBJECTIVES: In recent years, adjunctive therapies for epilepsy management are being explored due to considerable side effects carried by antiepileptic drugs (AEDs) and widespread reports of drug-resistant epilepsy. One such approach is non-invasive musical neurostimulation. Within this context, Mozart's sonata K448 has received particular attention following reports of reduced seizure frequency and a decrease in epileptiform discharges during and after music exposure; often described as the 'Mozart effect'...
April 17, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38635904/pharmacometric-in-silico-studies-used-to-facilitate-a-national-dose-standardisation-process-in-neonatology-application-to-amikacin
#32
JOURNAL ARTICLE
Verena Gotta, Julia Anna Bielicki, Paolo Paioni, Chantal Csajka, Dominic Stefan Bräm, Christoph Berger, Elisabeth Giger, Michael Buettcher, Klara M Posfay-Barbe, John Van den Anker, Marc Pfister
BACKGROUND AND AIMS: Pharmacometric in silico approaches are frequently applied to guide decisions concerning dosage regimes during the development of new medicines. We aimed to demonstrate how such pharmacometric modelling and simulation can provide a scientific rationale for optimising drug doses in the context of the Swiss national dose standardisation project in paediatrics using amikacin as a case study. METHODS: Amikacin neonatal dosage is stratified by post-menstrual age (PMA) and post-natal age (PNA) in Switzerland and many other countries...
April 8, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38635113/dapagliflozin-and-empagliflozin-in-paediatric-indications-a-systematic-review
#33
Sebastiano A G Lava, Craig Laurence, Alessandro Di Deo, Nicole Sekarski, Michael Burch, Oscar Della Pasqua
INTRODUCTION: In adults, sodium-glucose cotransporter type 2 inhibitors have revolutionised the treatment of type 2 diabetes mellitus, heart failure, and chronic kidney disease. OBJECTIVE: We aimed to review information on compassionate use, clinical pharmacology, efficacy, and safety of dapagliflozin and empagliflozin in children. METHODS: We conducted a systematic review of published clinical trials, case reports, and observational studies in Medline, Excerpta Medica, and Web of Science databases from inception to September 2023...
April 18, 2024: Paediatric Drugs
https://read.qxmd.com/read/38633683/concerns-of-primary-caregivers-of-children-with-complex-chronic-conditions-in-kerala-a-qualitative-analysis
#34
JOURNAL ARTICLE
Sajida Abdulla, Hariprasad Pallipurath Gopalakrishna Pillai, Reshmi Ramachandran
OBJECTIVES: Exploring data on primary caregiver experiences of dealing with chronically ill children (CIC) strengthens the ability of paediatricians to improve the quality of care by detecting unmet needs in paediatric palliative care and understanding their original concerns instead of presumed needs. Hence, this study aims to identify and describe the primary concerns and challenges faced by caregivers of children with complex chronic conditions in a tertiary care hospital in Kerala...
2024: Indian Journal of Palliative Care
https://read.qxmd.com/read/38632589/heparin-induced-dress-syndrome-in-a-paediatric-patient-and-successful-anaesthetic-management-in-cardiovascular-bypass-surgery-case-report
#35
JOURNAL ARTICLE
Laura Peña-Blanco, Laura Gutiérrez-Soriano, Félix Ramón Montes, Andrea Barragán-Méndez, Susana Beltrán-Villegas, Juan José López-Reyes, Carlos A Villa-Hincapié, Juan Pablo Umaña
BACKGROUND: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome is a severe adverse drug reaction marked by delayed hypersensitivity reactions causing skin and systemic complications. DRESS diagnosis is challenging due to the variety of clinical presentations and symptom overlap with other conditions. The perioperative period in these patients requires precise pharmacological strategies to prevent complications associated with this syndrome. The treatment of DRESS induced by unfractionated heparin during cardiopulmonary bypass (CPB) surgery presents some challenges that must be considered when selecting an anticoagulant to avoid side effects...
April 17, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38630199/population-pharmacokinetics-of-adalimumab-in-juvenile-idiopathic-arthritis-patients-a-retrospective-cohort-study-using-clinical-care-data
#36
JOURNAL ARTICLE
Amara Nassar-Sheikh Rashid, Femke Hooijberg, Sandy C Bergkamp, Mariken P Gruppen, Taco W Kuijpers, Mike Nurmohamed, Theo Rispens, Gertjan Wolbink, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Ron A A Mathôt
BACKGROUND AND OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder that primarily affects the joints in children. Notably, it is known to co-occur with uveitis. Adalimumab, a monoclonal anti-TNF antibody, is effective in treating both conditions. A deeper understanding of the pharmacokinetics (PK) of adalimumab in JIA is crucial to advance in more personalized treatment approaches. The objective of this study is to evaluate the population PK profile of adalimumab in JIA and to explain causes for its variability...
April 17, 2024: Paediatric Drugs
https://read.qxmd.com/read/38629915/protocol-for-a-randomized-controlled-trial-to-evaluate-a-permissive-blood-pressure-target-versus-usual-care-in-critically-ill-children-with-hypotension-pressure
#37
JOURNAL ARTICLE
Robert Darnell, Alanna Brown, Emma Laing, Julia Edwards, David A Harrison, Joseph C Manning, Mark J Peters, Padmanabhan Ramnarayan, Samiran Ray, Zia Sadique, Barnaby R Scholefield, Dermot Shortt, Lamprini Lampro, Carly Au, Kathy M Rowan, Paul Mouncey, David P Inwald
OBJECTIVES: Management of hypotension is a fundamental part of pediatric critical care, with cardiovascular support in the form of fluids or vasoactive drugs offered to every hypotensive child. However, optimal blood pressure (BP) targets are unknown. The PRotocolised Evaluation of PermiSSive BP Targets Versus Usual CaRE (PRESSURE) trial aims to evaluate the clinical and cost-effectiveness of a permissive mean arterial pressure (MAP) target of greater than a fifth centile for age compared with usual care...
April 17, 2024: Pediatric Critical Care Medicine
https://read.qxmd.com/read/38629225/the-use-of-ketorolac-may-reduce-opioid-exposure-in-infants-less-than-6-months-of-age-undergoing-congenital-heart-surgery
#38
JOURNAL ARTICLE
Janae Townsend, Hania Zaki, Rohali Keesari, Kevin Maher, Susan Hupp, Joshua W Branstetter
OBJECTIVES: Pain management for infants undergoing cardiothoracic surgery primarily utilises opioid analgesics. There is a paucity of data available for the use of non-steroidal anti-inflammatory medications such as ketorolac in this patient population. MATERIALS AND METHODS: This retrospective study evaluated patients between 30 days and 6 months undergoing cardiothoracic surgery. The primary endpoint evaluates ketorolac on reducing post-operative opioid use. RESULTS: Of 243 evaluated patient, 145 met inclusion...
April 17, 2024: Cardiology in the Young
https://read.qxmd.com/read/38618836/institutional-priority-setting-for-novel-drugs-and-therapeutics-a-qualitative-systematic-review
#39
JOURNAL ARTICLE
Daniel E Wang, Maram Hassanein, Yasmeen Razvi, Randi Zlotnik Shaul, Avram Denburg
BACKGROUND: There is a lack of guidance on approaches to formulary management and funding for high-cost drugs and therapeutics by individual healthcare institutions. The objective of this review was to assess institutional approaches to resource allocation for such therapeutics, with a particular focus on paediatric and rare disease populations. METHODS: A search of Embase and MEDLINE was conducted for studies relevant to decision-making for off-formulary, high-cost drugs and therapeutics...
2024: International Journal of Health Policy and Management
https://read.qxmd.com/read/38606841/the-role-of-viral-diagnostic-tests-in-respiratory-tract-infections-moving-forward
#40
JOURNAL ARTICLE
R Ortíz de Lejarazu, J M Eiros, F López-Medrano, M Montes, A Tagarro, M Tomás
The increased knowledge on virology and the increased potential of their diagnostic has risen several relevant question about the role of an early viral diagnosis and potential early treatment on the management of respiratory tract infections (RTI). In order to further understand the role of viral diagnostic tests in the management of RTI, a panel of experts was convened to discuss about their potential role, beyond what had been agreed in Influenza. The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI...
April 12, 2024: Revista Española de Quimioterapia: Publicación Oficial de la Sociedad Española de Quimioterapia
keyword
keyword
120024
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.